The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
Today's (02.02.2026) Total Trades: 201,725; Volume: 252,377,914 and Turnover: Tk. 7,462.417 million.
Today's (02.02.2026) Total Trades: 201,725; Volume: 252,377,914 and Turnover: Tk. 7,462.417 million.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
Techno Drugs Limited submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the quarter ended 31 December, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/TechnoDrugs_25.pdf
Techno Drugs Limited submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the quarter ended 31 December, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/TechnoDrugs_25.pdf